Navigation Links
KJT Group Hires Director of Health Outcomes
Date:7/9/2013

HONEOYE FALLS, N.Y., July 8, 2013 /PRNewswire/ -- KJT Group, Inc. is pleased to announce the hiring of Arun Changolkar, PhD, MBA as the Director of Health Outcomes Research to its expanding life sciences research and consulting organization.

Dr. Changolkar, of Philadelphia, brings extensive academic and professional experience in health economics and outcomes research. His experience includes leadership roles in the pharmaceutical and clinical research industries. With expertise in epidemiology and statistics his project experience spans both U.S. and global healthcare in oncology, vaccines, and autoimmune disease. 

He joins KJT Group after serving in various industry positions including Director of Global Health Outcomes at Stiefel and Manager of Health Outcomes and Analytics at GlaxoSmithKline. His experience includes the design and execution of HEOR studies to support multiple global country specific successful reimbursement submissions, supporting clinical trials, and various other post-marketing observational studies to generate clinical evidence.  He also participated in and contributed to strategic pricing, global value dossier synthesis, and core value development for various pharmaceutical products. Changolkar's accomplishments include numerous abstracts in international and national scientific meetings and 11 publications in scientific journals. 

"Arun brings a very nice mix of skills and experience to KJT Group's growing Health Outcomes Practice. Having worked on both the client and vendor sides he brings strong analytic skills as well as a clear understanding of the underlying business issues that our customers face," said Kenneth Tomaszewski, PhD, MS, Founder and CEO of KJT Group.

Following the completion of his PhD, Changolkar received post-doctoral training as an Anticancer Drug Discovery Researcher at Harvard Medical School and an Epigenetics Researcher at the University of Pennsylvania in Philadelphia.

As the Director of Health Outcomes Research at KJT Group, Changolkar will work closely with KJT Group researchers and oversee the design and conduct of KJT Group's health economics and outcomes research studies.

About KJT Group: KJT Group (www.kjtgroup.com) is a full service life sciences market research and insight consultancy firm. Established in 2007, KJT Group employs nearly 50 full-time staff in New York, Pennsylvania, Texas, South Carolina and The Netherlands. KJT Group is a member of the National Council on Public Polls (NCPP), Council of American Survey Research Organizations (CASRO) and the European Society Opinion and Marketing Research (ESOMAR).


'/>"/>
SOURCE KJT Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Smart Consulting Group and The Catalyst Group Form Alliance to Supply Quality Compliance Consulting Services For the Pharmaceutical Industry
2. Knowledgent Group Inc. Applies for Patent in Chemical Information Management
3. Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
4. Cellular Biomedicine Group Announces Appointment of Corporate Controller
5. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
6. The JTB Law Group Continues to Innovate with its New Video Information Series and Vivid Legal Cartoons
7. The Hemostemix Group of Companies Provides Corporate Strategy Update
8. Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab
9. YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group
10. Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group
11. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... SAN DIEGO, CALIF. (PRWEB) , ... October 10, 2017 , ... ... website as part of its corporate rebranding initiative announced today. The bold new ... broaden its reach, as the company moves into a significant growth period. , It ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... ... , ... At its national board meeting in North Carolina, ARCS® Foundation ... of Physics and Astronomy, has been selected for membership in ARCS Alumni Hall ... 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of ...
(Date:10/7/2017)...  The 2017 Nobel Prize in Chemistry recognizes ... Joachim Frank and Richard Henderson ... (cryo-EM) have helped to broaden the use ... The winners worked with systems manufactured by Thermo ... resolved, three-dimensional images of protein structures that lead ...
Breaking Biology Technology:
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017  IBM ... in dairy research, today announced a new collaboration using ... the chances that the global milk supply is impacted ... project, Cornell University has become the newest academic institution ... Chain, a food safety initiative that includes IBM Research, ...
(Date:5/16/2017)... N.J. , May 16, 2017  Veratad Technologies, ... provider of online age and identity verification solutions, announced ... K(NO)W Identity Conference 2017, May 15 thru May 17, ... Regan Building and International Trade Center. ... the globe and in today,s quickly evolving digital world, ...
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
Breaking Biology News(10 mins):